Pembrolizumab - emerging treatment of pulmonary sarcomatoid carcinoma: A case report

doi:10.12998/wjcc.v8.i1.97

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 8, Issue 1

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7163)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series.

Item

Count

PDF

404

WORD

218

HTML

4332

Figures (1-3)

362

Sum=5316

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

743

Download

1104

Sum=1847

Jan 6, 2020 (publication date) through Dec 31, 2024

Times Cited of This Article

Times Cited (10)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Clin Cases. Jan 6, 2020; 8(1): 97-102
Published online Jan 6, 2020. doi: 10.12998/wjcc.v8.i1.97

Full Size Figure Download Figure

Figure 2 Histological lung section. A: Hematoxylin and eosin staining showing sarcomatoid carcinoma, with visible spindle cells and rare epithelioid cells (magnification, 100 ×); B: Immunohistochemical staining showing sarcomatoid carcinoma with neoplastic cells positive for CK7 (magnification, 200 ×); C: Hematoxylin and eosin staining showing sarcomatoid carcinoma, with cells positive for programmed death-ligand-1 and tumor proportion score greater than 50% (magnification, 400×).

Citation: Cimpeanu E, Ahmed J, Zafar W, DeMarinis A, Bardarov SS, Salman S, Bloomfield D. Pembrolizumab - emerging treatment of pulmonary sarcomatoid carcinoma: A case report. World J Clin Cases 2020; 8(1): 97-102
URL: https://www.wjgnet.com/2307-8960/full/v8/i1/97.htm
DOI: https://dx.doi.org/10.12998/wjcc.v8.i1.97